Why the study?
Racial disparities are well described in cardiovascular disease, but the impact of race on post-TAVR outcomes remains unknown.
Does white race compared to black race affect in-hospital outcomes in patients post-TAVR?
Meta-Analysis (n=102,009)
Does white race compared to black race affect in-hospital outcomes in patients post-TAVR?
Odds Ratio: 1.01 (95% CI 0.86–1.19)
p-value: p=0.93
While in-hospital mortality post-TAVR is similar between black and white patients, black patients face higher risks of post-procedural MI and AKI, highlighting significant racial disparities in secondary outcomes.
Mortality equivalence supports inclusive TAVR referral; leaves open drivers of racial differences in periprocedural MI and AKI.
Racial disparities have been well described in cardiovascular disease. However, the impact of race on the outcomes post - Transcatheter aortic valve replacement (TAVR) remains unknown. We aim to evaluate the disparity among the race (black and white) post - TAVR. We systematically searched all electronic databases from inception until September 26, 2022. The primary outcome was in-hospital all-cause mortality, and secondary outcomes was myocardial infarction (MI), acute kidney injury (AKI), permanent pacemaker implantation (PPI) or ICD, stroke, vascular complications, and major bleeding. A total of three studies with 1,02,009 patients were included in the final analysis. The mean age of patients with white and black patients was 82.65 and 80.45 years, respectively. The likelihood of in-hospital all-cause mortality (OR, 1.01(95 %CI: 0.86–1.19), P = 0.93), stroke (OR, 0.83(95 %CI:0.61–1.13), P = 0.23, I2 = 46.57 %], major bleeding [OR, 1.05(95 %CI:0.92–1.20), P = 0.46), and vascular complications [OR, 0.92(95 %CI:0.81–1.06), P = 0.26), was comparable between white and black patients. However, patients with white race have lower odds of MI (OR, 0.65(95 %CI:0.50–0.84), P < 0.001), and AKI (OR, 0.84(95 %CI:0.74–0.95), P = 0.01) and higher odds of PPI or ICD (OR, 1.16(95 %CI: 1.06–1.27), P < 0.001, I2 = 0 %) compared with black race patients. Our findings suggest disparity post - TAVR outcomes existed, and black patients are at higher risk of MI and AKI than white patients. Key Clinical Message: What is already known on this topic: Disparity has been witnessed among patients with cardiovascular disease. However, no studies have drawn a significant association among post-TAVR patients' outcomes What this study adds: Among patients who underwent TAVR, there is a difference in the adverse outcomes between black and white race patients. White patients have a lower risk of post-procedure MI and AKI compared with Black patients. How this study might affect research, practice, or policy: These disparities need to be addressed, and proper guidelines need to be made along with engaging patients with better medical infrastructure and treatment options.
No takes yet. Share an insight, caveat, or question.
Jaiswal et al. (2023) conducted a meta-analysis in Transcatheter aortic valve replacement (TAVR) (n=102,009). White race vs. Black race was evaluated on in-hospital all-cause mortality (OR 1.01, 95% CI 0.86-1.19, p=0.93).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: